We hypothesize that SLE-related MHC variants may enhance the expression of specific HLA alleles, increasing antigen presentation efficiency and thereby enhancing immune surveillance of precancerous cells in endometrial and uterine cancer. The gene discussed is HLA-C; the disease is systemic lupus erythematosus.